Monalizumab Biosimilar – Anti-KLRC1, NKG2A, CD159a, CD94 mAb – Research Grade

(1 customer review)
Reference:
Size

,

Brand

Product type

Clonality

Expression system

Description of Monalizumab Biosimilar - Anti-KLRC1/NKG2A/CD159a/CD94 mAb - Research Grade

Description of Monalizumab Biosimilar - Anti-KLRC1/NKG2A/CD159a/CD94 mAb - Research Grade

General information on Anti-KLRC1/NKG2A/CD159a/CD94[Homo sapiens] (Monalizumab) Monoclonal Antibody

Monalizumab has been investigated for the treatment of Gynecologic Cancer, Chronic Lymphocytic Leukemia, and Squamous Cell Carcinoma of the Oral Cavity.

Product nameMonalizumab Biosimilar - Anti-KLRC1, NKG2A, CD159a, CD94 mAb - Research Grade
SourceCAS 1228763-95-8
SpeciesHumanized
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsIPH-2201,NN-8765,NNC-0141-0000-0100,NNC-141-01000,anti-NKG2A,humZ270
ReferencePX-TA1392
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody
SourceCAS 1228763-95-8
Product nameMonalizumab Biosimilar - Anti-KLRC1, NKG2A, CD159a, CD94 mAb - Research Grade
SourceCAS 1228763-95-8
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsIPH-2201,NN-8765,NNC-0141-0000-0100,NNC-141-01000,anti-NKG2A,humZ270
ReferencePX-TA1392
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody
SourceCAS 1228763-95-8

1 review for Monalizumab Biosimilar – Anti-KLRC1, NKG2A, CD159a, CD94 mAb – Research Grade

  1. Vele

    Great product!

Add a review

Your email address will not be published.


Clear
OK

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us to order

+33 (0)3 90 20 54 70

Write us

Categories: